Operating Expenses Summary of ScinoPharm Taiwan, Ltd.

ScinoPharm Taiwan, Ltd.'s latest annual operating expenses in 2023 was 901.49 Million TWD , up 6.68% from previous year.
ScinoPharm Taiwan, Ltd.'s latest quarterly operating expenses in 2024 Q2 was 196.9 Million TWD , down -2.27% from previous quarter.
ScinoPharm Taiwan, Ltd. reported a annual operating expenses of 845.13 Million TWD in annual operating expenses 2022, down -14.78% from previous year.
ScinoPharm Taiwan, Ltd. reported a annual operating expenses of 991.74 Million TWD in annual operating expenses 2021, up 5.29% from previous year.
ScinoPharm Taiwan, Ltd. reported a quarterly operating expenses of 196.9 Million TWD for 2024 Q2, down -2.27% from previous quarter.
ScinoPharm Taiwan, Ltd. reported a quarterly operating expenses of 247.15 Million TWD for 2024 Q3, up 25.52% from previous quarter.

Annual Operating Expenses Chart of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Historical Annual Operating Expenses of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	901.49 Million TWD	6.68%
2022	845.13 Million TWD	-14.78%
2021	991.74 Million TWD	5.29%
2020	941.95 Million TWD	3.59%
2019	909.33 Million TWD	-7.61%
2018	984.18 Million TWD	-0.71%
2017	991.19 Million TWD	5.71%
2016	937.68 Million TWD	1.16%
2015	926.95 Million TWD	-10.97%
2014	1.04 Billion TWD	-9.07%
2013	1.14 Billion TWD	8.62%
2012	1.05 Billion TWD	23.88%
2011	850.98 Million TWD	4.88%
2010	811.4 Million TWD	10.64%
2009	733.35 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	201.47 Million TWD	-24.73%
2024 Q2	196.9 Million TWD	-2.27%
2024 Q3	247.15 Million TWD	25.52%
2023 Q2	235.89 Million TWD	20.81%
2023 Q4	267.67 Million TWD	32.03%
2023 Q3	202.74 Million TWD	-14.05%
2023 Q1	195.26 Million TWD	-19.03%
2023 FY	901.56 Million TWD	6.68%
2022 Q3	183.39 Million TWD	-13.3%
2022 FY	845.13 Million TWD	-14.78%
2022 Q2	211.52 Million TWD	1.17%
2022 Q1	209.07 Million TWD	-23.58%
2022 Q4	241.14 Million TWD	31.49%
2021 Q3	237.4 Million TWD	4.9%
2021 FY	991.74 Million TWD	5.29%
2021 Q1	254.42 Million TWD	6.64%
2021 Q2	226.32 Million TWD	-11.04%
2021 Q4	273.58 Million TWD	15.24%
2020 Q2	231.68 Million TWD	16.69%
2020 Q4	238.59 Million TWD	-12.64%
2020 FY	941.95 Million TWD	3.59%
2020 Q3	273.13 Million TWD	17.89%
2020 Q1	198.54 Million TWD	-11.0%
2019 Q2	212.43 Million TWD	0.06%
2019 Q4	223.08 Million TWD	-14.7%
2019 FY	909.33 Million TWD	-7.61%
2019 Q3	261.52 Million TWD	23.11%
2019 Q1	212.29 Million TWD	-27.17%
2018 FY	984.18 Million TWD	-0.71%
2018 Q4	291.47 Million TWD	33.23%
2018 Q3	218.77 Million TWD	-16.11%
2018 Q2	260.79 Million TWD	22.35%
2018 Q1	213.14 Million TWD	-13.69%
2017 Q3	255.82 Million TWD	6.9%
2017 FY	991.19 Million TWD	5.71%
2017 Q2	239.31 Million TWD	-3.93%
2017 Q1	249.1 Million TWD	6.68%
2017 Q4	246.94 Million TWD	-3.47%
2016 Q1	235.88 Million TWD	-5.75%
2016 FY	937.68 Million TWD	1.16%
2016 Q4	233.51 Million TWD	0.33%
2016 Q3	232.74 Million TWD	-1.19%
2016 Q2	235.54 Million TWD	-0.14%
2015 Q2	238.76 Million TWD	17.43%
2015 FY	926.95 Million TWD	-10.97%
2015 Q1	203.31 Million TWD	-16.5%
2015 Q4	250.27 Million TWD	6.68%
2015 Q3	234.59 Million TWD	-1.75%
2014 Q4	243.5 Million TWD	-6.25%
2014 Q3	259.74 Million TWD	-9.62%
2014 Q2	287.38 Million TWD	14.73%
2014 FY	1.04 Billion TWD	-9.07%
2014 Q1	250.49 Million TWD	-28.66%
2013 Q4	351.1 Million TWD	35.04%
2013 FY	1.14 Billion TWD	8.62%
2013 Q1	266.42 Million TWD	-16.64%
2013 Q2	267.5 Million TWD	0.41%
2013 Q3	259.99 Million TWD	-2.81%
2012 Q2	238.51 Million TWD	-0.35%
2012 Q1	239.35 Million TWD	-4.73%
2012 Q4	319.61 Million TWD	24.56%
2012 Q3	256.6 Million TWD	7.58%
2012 FY	1.05 Billion TWD	23.88%
2011 Q4	251.24 Million TWD	20.06%
2011 FY	850.98 Million TWD	4.88%
2011 Q1	180.45 Million TWD	-23.98%
2011 Q2	210.02 Million TWD	16.39%
2011 Q3	209.26 Million TWD	-0.36%
2010 Q3	208.29 Million TWD	0.0%
2010 FY	811.4 Million TWD	10.64%
2010 Q4	237.36 Million TWD	13.96%
2009 FY	733.35 Million TWD	0.0%

Peer Operating Expenses Comparison of ScinoPharm Taiwan, Ltd.

Name	Operating Expenses	Operating Expenses Difference
Grape King Bio Ltd	6.03 Billion TWD	85.073%
Standard Chem & Pharm CO., LTD.	1.46 Billion TWD	38.499%
Maywufa Company Ltd.	854.37 Million TWD	-5.516%
Lotus Pharmaceutical Co., Ltd.	4.48 Billion TWD	79.881%
LIWANLI Innovation Co., Ltd.	54.86 Million TWD	-1543.09%
YungShin Global Holding Corporation	2.04 Billion TWD	55.975%
PhytoHealth Corporation	67.64 Million TWD	-1232.729%
SCI Pharmtech, Inc.	190.02 Million TWD	-374.415%
Formosa Laboratories, Inc.	1.24 Billion TWD	27.785%
PharmaEssentia Corporation	4.49 Billion TWD	79.945%
Bora Pharmaceuticals Co., LTD.	1.74 Billion TWD	48.252%

Global Stocks Search

ScinoPharm Taiwan, Ltd. (1789.TW)

Operating Expenses Summary of ScinoPharm Taiwan, Ltd.

Annual Operating Expenses Chart of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Historical Annual Operating Expenses of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Peer Operating Expenses Comparison of ScinoPharm Taiwan, Ltd.